mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.004 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.005 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.006 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.007 |